Search Results

You are looking at 31 - 40 of 2,919 items for :

  • Refine by Access: All x
Clear All
Full access

Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With Clostridium difficile Infection: A Nationwide Analysis

Arjun Gupta, Raseen Tariq, Ryan D. Frank, Gary W. Jean, Muhammad S. Beg, Darrell S. Pardi, David H. Johnson, and Sahil Khanna

Thus, elucidating the epidemiology of CDI and its impact on outcomes in patients with cancer is imperative. We used the National Hospital Discharge Survey (NHDS) database to evaluate the incidence of CDI in patients with both solid organ and

Full access

Indicators of Clinical Trajectory in Patients With Cancer Who Receive Cardiopulmonary Resuscitation

Sanjay Chawla, Cristina Gutierrez, Prabalini Rajendram, Kenneth Seier, Kay See Tan, Kara Stoudt, Marian Von-Maszewski, Jorge L. Morales-Estrella, Natalie T. Kostelecky, and Louis P. Voigt

evolved, striving for improved performance and better outcomes. 8 – 10 Although broadly implemented, CPR is most beneficial for acute, potentially reversible causes of cardiopulmonary arrest and should not be performed on patients with terminal or

Full access

Efficacy Trial of An Internet-Based Intervention for Cancer-Related Female Sexual Dysfunction

Leslie R. Schover, Ying Yuan, Bryan M. Fellman, Evan Odensky, Pamela E. Lewis, and Paul Martinetti

card on completing questionnaires at each follow-up. Items assessed background and medical history. The FSFI was the primary outcome measure. 29 The FSFI is a 19-item, multiple-choice questionnaire with excellent internal consistency, discriminant

Full access

Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women's Health Initiative

Rowan T. Chlebowski, Aaron K. Aragaki, and Garnet L. Anderson

,739 postmenopausal women with prior hysterectomy 12 ( Figure 1 ). The primary outcome monitored for benefit was coronary heart disease and the primary outcome monitored for harm was invasive breast cancer. A global index of time to first Figure 1 Women

Full access

Improving Cancer Pain Control With NCCN Guideline-Based Analgesic Administration: A Patient-Centered Outcome

Nora Janjan

Patient outcomes have become an integral end point as the nation’s medical training, research, and delivery system transforms into a patient-centered, value-based accreditation and reimbursement system. The components of patient-centered outcomes

Full access

Early Implementation of Palliative Care Can Improve Patient Outcomes

Paul A. Glare

palliative care-type treatment, given that this term is perceived to cause less distress to patients, their caregivers, and clinicians. 7 , 21 Symptom control and, therefore, quality of life are the end points of supportive care, while the main outcome is

Full access

VTE as a Quality Indicator

Myron Goldsmith, George Whitelaw, and Denise A. Cannaday

Venous thromboembolism (VTE) is still the most common preventable cause of hospital death, with cancer a known significant risk factor for its development. Prophylaxis to prevent VTE in hospitalized surgical and medical patients has been suboptimal, and efforts for improvement have been unsuccessful. Recent practice guidelines on VTE in oncology from the National Comprehensive Cancer Network and American Society of Clinical Oncologists have further highlighted this relationship and could bridge performance measures and outcomes that can affect the strategies for preventing deep venous thrombosis and pulmonary embolism in oncology patients. Hospitals and physicians with poor performance data will have problems with payment from the Centers for Medicare & Medicaid Services and contracting the best rates from other payors. Hospital accreditation from The Joint Commission could be an issue for poorly performing institutions, as could consumer acceptance. The authors believe that specific oncology VTE measures should be developed to help decrease the current poor rates of VTE prophylaxis and also improve hospital and physician compliance.

Full access

21-Gene Recurrence Score and Survival Outcomes in the Phase III Multicenter TAILORx Clinical Trial

Sherry X. Yang, John Yu, and Molin Wang

provide opportunities to address critical questions, such as a biomarker’s performance in predicting BCSS and OS relative to recurrence outcomes in early-stage breast cancer. The current study was designed to evaluate the association of RS with OS, BCSS

Full access

Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer

Emily van Seventer, J. Peter Marquardt, Amelie S. Troschel, Till D. Best, Nora Horick, Chinenye Azoba, Richard Newcomb, Eric J. Roeland, Michael Rosenthal, Christopher P. Bridge, Joseph A. Greer, Areej El-Jawahri, Jennifer Temel, Florian J. Fintelmann, and Ryan D. Nipp

Background Patients with cancer often experience loss of skeletal muscle, which adversely impacts clinical outcomes. 1 , 2 Although most patients with cancer experience some degree of muscle loss, severe muscle loss contributes to approximately 20

Full access

Outcomes of Patients With Cancer Discharged to a Skilled Nursing Facility After Acute Care Hospitalization

Sarguni Singh, Megan Eguchi, Sung-Joon Min, and Stacy Fischer

palliative care consultation remains limited for patients in SNFs. 10 We sought to understand clinical outcomes of patients with stage II–IV pancreatic, colorectal, lung, and bladder cancers who discharge to an SNF compared with patients who discharge to home